Rhenman & Partners Asset Management AB

Latest statistics and disclosures from Rhenman & Partners Asset Management AB's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are LLY, ABC, MDT, BSX, REGN, and represent 14.80% of Rhenman & Partners Asset Management AB's stock portfolio.
  • Added to shares of these 10 stocks: HCA (+$11M), MDT (+$8.5M), TECH (+$7.5M), THC (+$6.2M), ABC (+$6.1M), SWAV (+$5.6M), OSH (+$5.4M), MRTX, IQV, REGN.
  • Started 7 new stock positions in NUVL, OSH, IQV, IGMS, MRSN, TECH, RLAY.
  • Reduced shares in these 10 stocks: Abiomed (-$22M), ISRG (-$12M), UNH (-$8.9M), HZNP (-$8.1M), TMO (-$6.9M), BSX (-$5.1M), CVS (-$5.0M), VRTX, CI, MCK.
  • Sold out of its positions in Abiomed, GH, PGNY, HZNP.
  • Rhenman & Partners Asset Management AB was a net buyer of stock by $840k.
  • Rhenman & Partners Asset Management AB has $959M in assets under management (AUM), dropping by 0.36%.
  • Central Index Key (CIK): 0001599882

Tip: Access up to 7 years of quarterly data

Positions held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB holds 93 positions in its portfolio as reported in the December 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Eli Lilly & Co. (LLY) 3.4 $32M -9% 88k 365.84
AmerisourceBergen (ABC) 3.0 $29M +27% 173k 165.71
Medtronic SHS (MDT) 2.8 $27M +45% 350k 77.72
Boston Scientific Corporation (BSX) 2.8 $27M -15% 585k 46.27
Regeneron Pharmaceuticals (REGN) 2.8 $27M +15% 37k 721.49
BioMarin Pharmaceutical (BMRN) 2.7 $26M +7% 254k 103.49
Merck & Co (MRK) 2.5 $24M 215k 110.95
Gilead Sciences (GILD) 2.4 $23M 270k 85.85
Vertex Pharmaceuticals Incorporated (VRTX) 2.4 $23M -16% 80k 288.78
Anthem (ELV) 2.4 $23M +12% 45k 512.97
Tenet Healthcare Corp Com New (THC) 2.4 $23M +36% 471k 48.79
Thermo Fisher Scientific (TMO) 2.3 $22M -23% 40k 550.69
Hca Holdings (HCA) 2.3 $22M +109% 90k 239.96
Becton, Dickinson and (BDX) 2.2 $21M -2% 83k 254.30

Setup an alert

Rhenman & Partners Asset Management AB will file the next quarterly 13-HR in about 2 months. Would you like to be notified?

Abbvie (ABBV) 2.2 $21M -13% 130k 161.61
Cigna Corp (CI) 2.1 $21M -17% 62k 331.34
Jazz Pharmaceuticals Shs Usd (JAZZ) 2.1 $20M -2% 128k 159.31
UnitedHealth (UNH) 2.1 $20M -30% 38k 530.18
Humana (HUM) 2.1 $20M -11% 39k 512.19
Pfizer (PFE) 1.9 $18M 350k 51.24
Johnson & Johnson (JNJ) 1.8 $18M 100k 176.65
Alnylam Pharmaceuticals (ALNY) 1.8 $17M -2% 73k 237.65
Biontech Se Sponsored Ads (BNTX) 1.7 $16M +10% 109k 150.22
CVS Caremark Corporation (CVS) 1.7 $16M -24% 171k 93.19
Cooper Cos Com New (COO) 1.6 $16M 47k 330.67
Inspire Med Sys (INSP) 1.6 $15M -3% 61k 251.88
McKesson Corporation (MCK) 1.5 $15M -22% 39k 375.12
Axonics Modulation Technolog (AXNX) 1.5 $14M +9% 230k 62.53
Mirati Therapeutics (MRTX) 1.4 $14M +52% 300k 45.31
Danaher Corporation (DHR) 1.4 $13M -19% 50k 265.42
Harmony Biosciences Hldgs In (HRMY) 1.4 $13M 240k 55.10
Abbott Laboratories (ABT) 1.3 $13M 117k 109.79
Edwards Lifesciences (EW) 1.1 $11M +15% 144k 74.61
Silk Road Medical Inc Common (SILK) 1.1 $10M +26% 196k 52.85
Apellis Pharmaceuticals (APLS) 1.1 $10M -9% 200k 51.71
Neurocrine Biosciences (NBIX) 1.1 $10M +2% 85k 119.44
Cytokinetics Com New (CYTK) 1.0 $9.9M +3% 216k 45.82
Shockwave Med (SWAV) 1.0 $9.7M +135% 47k 205.61
Outset Med (OM) 1.0 $9.3M +5% 360k 25.82
Iveric Bio (ISEE) 1.0 $9.2M +17% 430k 21.41
Immunocore Hldgs Ads (IMCR) 0.9 $8.6M 150k 57.07
Insulet Corporation (PODD) 0.9 $8.5M 29k 294.39
Royalty Pharma Shs Class A (RPRX) 0.9 $8.5M 215k 39.52
Privia Health Group (PRVA) 0.9 $8.4M +33% 370k 22.71
Dynavax Technologies Corp Com New (DVAX) 0.9 $8.3M +6% 784k 10.64
Biogen Idec (BIIB) 0.9 $8.3M -8% 30k 276.92
Revance Therapeutics (RVNC) 0.8 $8.1M +12% 438k 18.46
Xencor (XNCR) 0.8 $7.7M 294k 26.04
Bio-techne Corporation (TECH) 0.8 $7.5M NEW 90k 82.88
ImmunoGen (IMGN) 0.8 $7.4M +36% 1.5M 4.96
Natera (NTRA) 0.7 $6.6M +106% 165k 40.17
Intra Cellular Therapies (ITCI) 0.7 $6.6M 125k 52.92
Karuna Therapeutics Ord (KRTX) 0.6 $5.9M +50% 30k 196.50
West Pharmaceutical Services (WST) 0.6 $5.9M +47% 25k 235.35
Esperion Therapeutics (ESPR) 0.6 $5.6M 900k 6.23
Veeva Sys Cl A Com (VEEV) 0.6 $5.6M 35k 161.38
Iovance Biotherapeutics (IOVA) 0.6 $5.5M +69% 864k 6.39
Envista Hldgs Corp (NVST) 0.6 $5.5M +13% 164k 33.67
EXACT Sciences Corporation (EXAS) 0.6 $5.4M +44% 110k 49.51
Oak Street Health (OSH) 0.6 $5.4M NEW 250k 21.51
Seagen (SGEN) 0.5 $5.3M 41k 128.51
Olink Hldg Ab Sponsored Ads (OLK) 0.5 $4.9M 194k 25.38
Phreesia (PHR) 0.5 $4.9M +20% 150k 32.36
Viewray (VRAY) 0.5 $4.5M 1.0M 4.48
R1 RCM (RCM) 0.4 $4.1M 378k 10.95
Agilon Health (AGL) 0.4 $4.1M 255k 16.14
Iqvia Holdings (IQV) 0.4 $4.1M NEW 20k 204.89
Alkermes SHS (ALKS) 0.4 $3.9M 150k 26.13
Alignment Healthcare (ALHC) 0.4 $3.8M +18% 325k 11.76
Glaukos (GKOS) 0.4 $3.7M 85k 43.68
Meiragtx Holdings (MGTX) 0.4 $3.6M 555k 6.52
Teladoc (TDOC) 0.3 $3.1M 130k 23.65
Relay Therapeutics (RLAY) 0.3 $3.0M NEW 200k 14.94
Arvinas Ord (ARVN) 0.3 $2.9M +70% 85k 34.21
10x Genomics Cl A Com (TXG) 0.3 $2.7M 75k 36.44
Phathom Pharmaceuticals (PHAT) 0.3 $2.6M 235k 11.22
Sangamo Biosciences (SGMO) 0.3 $2.6M 820k 3.14
Novocure Ord Shs (NVCR) 0.3 $2.6M 35k 73.35
Nuvalent Inc-a (NUVL) 0.2 $2.4M NEW 80k 29.78
Mersana Therapeutics (MRSN) 0.2 $2.3M NEW 400k 5.86
Allogene Therapeutics (ALLO) 0.2 $2.1M 340k 6.29
G1 Therapeutics (GTHX) 0.2 $2.0M 370k 5.43
Health Catalyst (HCAT) 0.2 $1.9M 180k 10.63
Ionis Pharmaceuticals (IONS) 0.2 $1.9M 50k 37.77
Rigel Pharmaceuticals Com New (RIGL) 0.2 $1.8M 1.2M 1.50
Intellia Therapeutics (NTLA) 0.2 $1.7M 50k 34.89
Stereotaxis Com New (STXS) 0.2 $1.7M 797k 2.07
Intuitive Surgical Com New (ISRG) 0.1 $1.3M -90% 5.0k 265.35
Nektar Therapeutics (NKTR) 0.1 $1.2M 550k 2.26
Nkarta (NKTX) 0.1 $1.2M 200k 5.99
Essa Pharma Com New (EPIX) 0.1 $945k 375k 2.52
Igm Biosciences (IGMS) 0.1 $851k NEW 50k 17.01
Rapid Micro Biosystems Class A Com (RPID) 0.0 $339k 300k 1.13

Past Filings by Rhenman & Partners Asset Management AB

SEC 13F filings are viewable for Rhenman & Partners Asset Management AB going back to 2013

View all past filings